NOVARTIS has signed an exclusive
worldwide licensing agreement
with the Global Alliance for TB Drug
Development for compounds to
fight tuberculosis (TB) that have
been discovered at the Novartis
Institutes for Tropical Diseases.
Current therapies for TB required
six to 30 month dosing regimes
and there were increasingly drug
resistant strains of TB emerging,
Novartis said.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Aug 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.